ConMed Corporation (ConMed) is a US-based medical technology company, engaged in the manufacturing and selling of surgical devices and equipment for minimally invasive procedures and monitoring. The company's products are used by surgeons and physicians in a variety of specialties, including orthopedics, general surgery, gynecology, neurosurgery and gastroenterology. ConMed caters its products to caregivers in orthopedic, general surgery, gynecology, gastroenterology, pulmonology, anesthesiology markets, and sports medicine. ConMed operates in North America, Europe, Asia and Australia. The company's key product areas include: Orthopedic Surgery, Surgical Visualization and General Surgery. ConMed offers a range of Orthopedic Surgery devices and products to repair injuries which have occurred in the articulating joint areas of the body. Its product line includes sports medicine, powered surgical instruments, and sports biologics and tissue. The company markets its orthopedic surgery products under the brands, including Hall, ConMed Linvatec, Concept and Shutt. ConMed's sports medicine products include powered resection instruments, arthroscopes, reconstructive systems, tissue repair sets, metal and bio-absorbable implants as well as related disposable products and fluid management systems. Its powered instruments are used in large and small bone orthopedic, arthroscopic, oral/maxillofacial, podiatric, plastic, ENT (ears, nose and throat), neurological, spinal and cardiothoracic surgeries. In FY2016, the Orthopedic surgery category reported revenue of US$370.47 million, which accounted for 48.5% of the company’s total revenue. The company's Surgical Visualization product line offers endoscopic imaging and capture devices for the surgical needs, including two dimensional high-definitions (2DHD) and three dimensional high-definition (3DHD) vision technologies. These technologies are used by surgeons during complex minimally invasive orthopedic and general surgery procedures. In FY2016, the Surgical Visualization products reported revenue of US$51.63 million which accounted for 6.8% of the company’s total revenue. ConMed's general surgery product line offers a range of products in the areas of advanced surgical, endoscopic technologies, and critical care. The company's advanced products offer electrosurgical generators, handpieces, smoke management systems and accessories surgical. The company's endomechanical instrumentation products offer instruments, such as trocars, suction irrigation devices, graspers, scissors and dissectors used in the minimally invasive laparoscopic and gynecological surgery. It also provides premium uterine manipulator, VCARE, for use in laparoscopic hysterectomies and other gynecologic laparoscopic procedures. The company's endoscopic technologies offering includes mucosal management devices, forceps, scope management accessories, bronchoscopy devices, dilatation, stricture management devices, hemostasis, biliary devices and polypectomy. ConMed's critical care includes a line of vital signs and cardiac monitoring products, including pulse oximetry equipment and sensors, electrocardiogram (ECG) electrodes and cables, cardiac defibrillation and pacing pads, and blood pressure cuffs. It also offers a range of suction and tubing instruments for use in the operating rooms, as well as a line of IV products for use in the critical care areas of the hospital. In FY2016, the General surgery products reported revenue of US$341.41 million, which accounted for 44.7% of the company’s total revenue The company’s R&D activities focus on the development and enhancement of products and processes, applying technology to expand existing product lines. In FY2016, ConMed spent US$32.3 million on its R&D activities, which as a percentage of revenue stood at 4.2%. Geographically, the company operates into four regions, namely, the US, Americas (excluding the US) Europe, Middle East and Africa and Asia Pacific. In FY2016, the US region accounted for 52.3% of the company's total revenue, followed by Europe, Middle East & Africa with 19.4%; Asia Pacific with 16.9% and Americas (excluding the United States) with 11.5% of the company’s total revenue. The company's subsidiaries include Aspen Laboratories, ConMed Andover Medical, ConMed Endoscopic Technologies, ConMed Italia SrL, ConMed Linvatec Australia and Linvatec Korea.
Scope of the Report
-- About the Company - Historical Details, Current Ownership Structure and basic overview of CONMED Corporation in terms of revenue, net income, and operating income.
-- Financials - Details about CONMED Corporation listing status, annual financial reports (for the past 5 years), key financial highlights and region wise and category wise breakdown of their net revenue.
-- Products / Services - Listing of the company’s entire portfolio along with description of individual products / services providing a clear picture of their target audience.
-- Company SWOT Analysis - Outlines CONMED Corporation’s strengths, weaknesses, and opportunities and threats facing the company.
-- Recent Developments - Showcases CONMED Corporation’s recent developments including mergers, acquisitions, partnerships, collaborations, new product launches, investment and divestment plans.
-- Strategic Evaluation - Provides an overview of CONMED Corporation’s corporate goals and strategic initiatives and evaluates their outcomes along with outlining any persisting legal issues and outlook of our in-house analyst panel on the particular company.
-- Technology Landscape - Details how the company allocates its IT budget across the core areas of its business, CIO/CTO Profile, Key IT Initiatives and Deals undertaken buy the company at present along with outlook.
Key Questions Answered
-- What domain does CONMED Corporation operate and what are key points about it?
-- What is the product / service portfolio of CONMED Corporation?
-- How has CONMED Corporation performed financially from the 2013?
-- How does CONMED Corporation rank among its peers in terms of revenue and market share?
-- What are CONMED Corporation strengths and weaknesses and what opportunities and threats does it face?
-- What are CONMED Corporation’s main growth strategies and how successful has the company been at implementing them?
-- What is the in-house technical capability of CONMED Corporation? Where does it procure / outsource it?
Reasons to buy
-- Report delivered in easily accessible PPT format which can be used to gain insights quickly and further prepare presentations of your own
-- Lean pricing structure ultimately giving you vast access to the unlimited knowledge repository of the company profiles at very competitive cost
-- 12 hour delivery time fulfilling your urgent requests as per your requirement
-- On-demand customization options that can completely cater to your needs by focusing the report onto given specifics
1. About the Company
1.1 History and Basic Facts
1.2 Ownership Structure and Key Executives
1.3 Head Office
1.4 Other Locations & Subsidiaries
1.5 List of Competitors
1.6 Employee Count & Distribution
2.1 Company Type (Listed / Unlisted)
2.2 Annual Statements
2.3 Key Financial Highlights
2.4 Region-wise Breakdown
3. Product / Services
4. SWOT Analysis
4.1 SWOT Overview
5. Recent Developments
5.1 Mergers & Acquisitions
5.2 Partnerships, Collaborations & Joint Ventures
5.3 New Product Launches
5.4 Business Expansion / Divestment
6. Strategic Evaluation
6.1 Corporate Strategy
6.2 Legal Issues
6.3 Analyst Outlook
7. Technology Landscape
-- 7.1.1 Industry Snapshot
-- 7.1.2 IT Spend
-- 7.1.3 Key Information Technology Trends
-- 7.2.1 IT Overview
-- 7.2.2 Key IT Technologies
-- 7.2.3 Recent IT Initiatives
-- 7.2.4 IT Outsourcing Engagements
-- 7.2.5 Key IT Management
-- 7.2.6 CIO/CTO Profile
-- About Us
-- Contact Us
Fig.1: Company Snapshot
Fig.2: Locations Listing on Map
Table.1: Ownership Structure
Table.2: List of Competitors
Table.3: Annual Statements
Table.4: Key Financial Highlights
Table.5: Region-wise Breakdown
Table.6: Product/Services Overview
Table.7: Mergers & Acquisitions
Table.8: Partnerships, Collaborations & Joint Ventures
Table.9: New Product Launches
Table.10: Business Expansion / Divestment
Table 11: IT Budgets
Table 12: Key IT Management (CIO / CTO)
Table 13: IT Deals undertaken in the past years